President and Managing Director of Galen, Dr Dennise Broderick, has said, ‘As the global spread of COVID-19 escalates and local and national governments enhance restrictions on people’s movements, we wish to reassure you that, as a result of the essential nature of the work we carry out, Galen will continue to conduct our critical business operations in all of our locations.

‘We are constantly monitoring the rapidly changing situation and continue to take guidance from governments and health officials to ensure our processes, policies and procedures are adapted as required.

‘The health and safety of our employees and our ability to ensure the delivery of medicines to patients is, and always has been, our top priority and we are committed to ensure this continues.’

Dr Broderick continued, ‘As the Coronavirus outbreak escalated Galen’s business continuity plan moved into a further phase, with the following actions being taken:

  • Review of all staffing arrangements and shift patterns to ensure that Galen resource and capacity is maximised
  • Introduction of social distancing, to include a reduction of face-to-face meetings
  • Remote working for all employees where their role permits
  • Focus on utilising technology to support virtual / remote meetings both internally and externally

‘All employees have been issued with guidance on health and hygiene best practice and requested to report any symptoms associated with the virus immediately. All of this has been done to ensure that we continue to offer our clients an uninterrupted and unhindered level of service. We fully appreciate the criticality of maintaining global supply chains. Our teams are fully appraised of all actions and changes required and are committed to keeping you informed at all stages during this outbreak.

‘Should you have any additional concerns regarding your partnership with Galen, please do not hesitate to contact your Galen representative.

‘Please continue to check for the latest information as this global situation continues to evolve.’

For more information, visit www.galen-pharma.com.